Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection

Anand Jillella, Celalettin Ustun, Eric Robach, Durdu Sertkaya, Cecily Dipiro, Andre M. Kallab, Wendy G. Brick, Paul M Dainer, Abdullah Kutlar, Andrea R. Townsend, Russell E. Burgess

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The purpose of this retrospective study was to evaluate infectious complications in patients receiving mobilization chemotherapy for stem cell collection prior to autologous peripheral blood stem cell transplantation. An additional goal was to evaluate risk factors associated with the development of infectious complications. At the Medical College of Georgia BMT center, 54 patients were administered mobilization chemotherapy for the purpose of collecting stem cells between June, 1997, and May, 2002. All patients received Filgrastim in addition to chemotherapy, and 50 of 54 patients received prophylactic acyclovir, fluconazole, and ciprofloxacin until neutrophil recovery. The median duration to neutrophil recovery was 11 days. Fourteen of 54 (26%) patients developed fever/infections during the mobilization phase. One patient developed both a catheter-related infection and Clostridium difficile colitis, increasing the total number of infectious episodes to 15. Twelve patients had a documented site of infection whereas 2 patients had neutropenic fever with no identifiable source. Eight of the 15 (55%) infections were Gram-positive catheter infections. All the patients were treated successfully with antibiotics. No systemic fungal infections were identified and none of the patients died from complications related to mobilization chemotherapy. Logistic regression was applied for univariate and multivariate analysis and showed that age, sex, diagnosis, neutrophil recovery, disease status, use of salvage chemotherapy, and mobilization regimen used did not affect the infection rate. In our series of 54 patients, 14 patients developed fever/infections during mobilization. Although there is a substantial risk of infectious complications among patients who receive mobilization chemotherapy, it is not clear that prophylactic antibiotics decrease infectious complications. Because the vast majority of infections are Gram-positive catheter infections, it appears reasonable to employ Gram-positive prophylaxis. Controlled studies should be conducted to define the optimum mobilization regimens as well as the optimum combination of prophylactic antibiotics.

Original languageEnglish (US)
Pages (from-to)155-160
Number of pages6
JournalJournal of Hematotherapy and Stem Cell Research
Volume12
Issue number2
DOIs
StatePublished - Apr 1 2003

Fingerprint

Drug Therapy
Infection
Neutrophils
Fever
Anti-Bacterial Agents
Peripheral Blood Stem Cells
Catheters
Hematopoietic Stem Cell Mobilization
Peripheral Blood Stem Cell Transplantation
Catheter-Related Infections
Acyclovir
Clostridium difficile
Mycoses
Fluconazole
Colitis
Ciprofloxacin
Stem Cells
Multivariate Analysis
Retrospective Studies
Logistic Models

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection. / Jillella, Anand; Ustun, Celalettin; Robach, Eric; Sertkaya, Durdu; Dipiro, Cecily; Kallab, Andre M.; Brick, Wendy G.; Dainer, Paul M; Kutlar, Abdullah; Townsend, Andrea R.; Burgess, Russell E.

In: Journal of Hematotherapy and Stem Cell Research, Vol. 12, No. 2, 01.04.2003, p. 155-160.

Research output: Contribution to journalArticle

Jillella, Anand ; Ustun, Celalettin ; Robach, Eric ; Sertkaya, Durdu ; Dipiro, Cecily ; Kallab, Andre M. ; Brick, Wendy G. ; Dainer, Paul M ; Kutlar, Abdullah ; Townsend, Andrea R. ; Burgess, Russell E. / Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection. In: Journal of Hematotherapy and Stem Cell Research. 2003 ; Vol. 12, No. 2. pp. 155-160.
@article{cf4da5a9e00d456681730c022dc1ceff,
title = "Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection",
abstract = "The purpose of this retrospective study was to evaluate infectious complications in patients receiving mobilization chemotherapy for stem cell collection prior to autologous peripheral blood stem cell transplantation. An additional goal was to evaluate risk factors associated with the development of infectious complications. At the Medical College of Georgia BMT center, 54 patients were administered mobilization chemotherapy for the purpose of collecting stem cells between June, 1997, and May, 2002. All patients received Filgrastim in addition to chemotherapy, and 50 of 54 patients received prophylactic acyclovir, fluconazole, and ciprofloxacin until neutrophil recovery. The median duration to neutrophil recovery was 11 days. Fourteen of 54 (26{\%}) patients developed fever/infections during the mobilization phase. One patient developed both a catheter-related infection and Clostridium difficile colitis, increasing the total number of infectious episodes to 15. Twelve patients had a documented site of infection whereas 2 patients had neutropenic fever with no identifiable source. Eight of the 15 (55{\%}) infections were Gram-positive catheter infections. All the patients were treated successfully with antibiotics. No systemic fungal infections were identified and none of the patients died from complications related to mobilization chemotherapy. Logistic regression was applied for univariate and multivariate analysis and showed that age, sex, diagnosis, neutrophil recovery, disease status, use of salvage chemotherapy, and mobilization regimen used did not affect the infection rate. In our series of 54 patients, 14 patients developed fever/infections during mobilization. Although there is a substantial risk of infectious complications among patients who receive mobilization chemotherapy, it is not clear that prophylactic antibiotics decrease infectious complications. Because the vast majority of infections are Gram-positive catheter infections, it appears reasonable to employ Gram-positive prophylaxis. Controlled studies should be conducted to define the optimum mobilization regimens as well as the optimum combination of prophylactic antibiotics.",
author = "Anand Jillella and Celalettin Ustun and Eric Robach and Durdu Sertkaya and Cecily Dipiro and Kallab, {Andre M.} and Brick, {Wendy G.} and Dainer, {Paul M} and Abdullah Kutlar and Townsend, {Andrea R.} and Burgess, {Russell E.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1089/152581603321628296",
language = "English (US)",
volume = "12",
pages = "155--160",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection

AU - Jillella, Anand

AU - Ustun, Celalettin

AU - Robach, Eric

AU - Sertkaya, Durdu

AU - Dipiro, Cecily

AU - Kallab, Andre M.

AU - Brick, Wendy G.

AU - Dainer, Paul M

AU - Kutlar, Abdullah

AU - Townsend, Andrea R.

AU - Burgess, Russell E.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - The purpose of this retrospective study was to evaluate infectious complications in patients receiving mobilization chemotherapy for stem cell collection prior to autologous peripheral blood stem cell transplantation. An additional goal was to evaluate risk factors associated with the development of infectious complications. At the Medical College of Georgia BMT center, 54 patients were administered mobilization chemotherapy for the purpose of collecting stem cells between June, 1997, and May, 2002. All patients received Filgrastim in addition to chemotherapy, and 50 of 54 patients received prophylactic acyclovir, fluconazole, and ciprofloxacin until neutrophil recovery. The median duration to neutrophil recovery was 11 days. Fourteen of 54 (26%) patients developed fever/infections during the mobilization phase. One patient developed both a catheter-related infection and Clostridium difficile colitis, increasing the total number of infectious episodes to 15. Twelve patients had a documented site of infection whereas 2 patients had neutropenic fever with no identifiable source. Eight of the 15 (55%) infections were Gram-positive catheter infections. All the patients were treated successfully with antibiotics. No systemic fungal infections were identified and none of the patients died from complications related to mobilization chemotherapy. Logistic regression was applied for univariate and multivariate analysis and showed that age, sex, diagnosis, neutrophil recovery, disease status, use of salvage chemotherapy, and mobilization regimen used did not affect the infection rate. In our series of 54 patients, 14 patients developed fever/infections during mobilization. Although there is a substantial risk of infectious complications among patients who receive mobilization chemotherapy, it is not clear that prophylactic antibiotics decrease infectious complications. Because the vast majority of infections are Gram-positive catheter infections, it appears reasonable to employ Gram-positive prophylaxis. Controlled studies should be conducted to define the optimum mobilization regimens as well as the optimum combination of prophylactic antibiotics.

AB - The purpose of this retrospective study was to evaluate infectious complications in patients receiving mobilization chemotherapy for stem cell collection prior to autologous peripheral blood stem cell transplantation. An additional goal was to evaluate risk factors associated with the development of infectious complications. At the Medical College of Georgia BMT center, 54 patients were administered mobilization chemotherapy for the purpose of collecting stem cells between June, 1997, and May, 2002. All patients received Filgrastim in addition to chemotherapy, and 50 of 54 patients received prophylactic acyclovir, fluconazole, and ciprofloxacin until neutrophil recovery. The median duration to neutrophil recovery was 11 days. Fourteen of 54 (26%) patients developed fever/infections during the mobilization phase. One patient developed both a catheter-related infection and Clostridium difficile colitis, increasing the total number of infectious episodes to 15. Twelve patients had a documented site of infection whereas 2 patients had neutropenic fever with no identifiable source. Eight of the 15 (55%) infections were Gram-positive catheter infections. All the patients were treated successfully with antibiotics. No systemic fungal infections were identified and none of the patients died from complications related to mobilization chemotherapy. Logistic regression was applied for univariate and multivariate analysis and showed that age, sex, diagnosis, neutrophil recovery, disease status, use of salvage chemotherapy, and mobilization regimen used did not affect the infection rate. In our series of 54 patients, 14 patients developed fever/infections during mobilization. Although there is a substantial risk of infectious complications among patients who receive mobilization chemotherapy, it is not clear that prophylactic antibiotics decrease infectious complications. Because the vast majority of infections are Gram-positive catheter infections, it appears reasonable to employ Gram-positive prophylaxis. Controlled studies should be conducted to define the optimum mobilization regimens as well as the optimum combination of prophylactic antibiotics.

UR - http://www.scopus.com/inward/record.url?scp=12444334522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444334522&partnerID=8YFLogxK

U2 - 10.1089/152581603321628296

DO - 10.1089/152581603321628296

M3 - Article

VL - 12

SP - 155

EP - 160

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 2

ER -